What is the recent news on Crestor all about?

In March of 2004, the activist group Public Citizen complained to the US Food and Drug Administration (FDA) that a condition called rhabdomyolysis was occurring more frequently with Crestor than with other statins.

Rhabdomyolysis is a serious condition that involves muscle damage and affects the kidneys. This condition is known to be a very rare side effect of all currently marketed statins, the class of cholesterol medication that includes Crestor. In medical circles, "very rare" is defined as occurring in fewer than 1 in 10,000 cases.

As with all other currently marketed statins, the rate of rhabdomyolysis with Crestor is very rare-less than 1 in 10,000.

The information on this page is meant to provide a general overview of the law. The laws in your state and/or city may deviate significantly from those described here. If you have specific questions related to your situation you should speak with a local attorney.

Additional Crestor Articles

Search LawInfo's Crestor Resources